MAP4K1

mitogen-activated protein kinase kinase kinase kinase 1, the group of Mitogen-activated protein kinase kinase kinase kinases

Basic information

Region (hg38): 19:38587641-38618882

Links

ENSG00000104814NCBI:11184OMIM:601983HGNC:6863Uniprot:Q92918AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MAP4K1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAP4K1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
missense
26
clinvar
1
clinvar
27
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 26 5 0

Variants in MAP4K1

This is a list of pathogenic ClinVar variants found in the MAP4K1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-38587707-G-C Likely benign (Jul 07, 2018)1223674
19-38587810-C-T not specified Likely benign (Dec 19, 2023)3123073
19-38593286-G-C not specified Uncertain significance (Dec 13, 2023)3123072
19-38593306-G-A not specified Uncertain significance (Apr 18, 2023)2538429
19-38593312-G-T not specified Uncertain significance (Jan 26, 2022)2363757
19-38595489-T-A not specified Uncertain significance (Mar 29, 2023)2531406
19-38595698-G-T Likely benign (Mar 01, 2024)2649816
19-38595707-C-A Likely benign (Mar 01, 2024)2649817
19-38596318-T-G not specified Uncertain significance (Nov 06, 2023)3123071
19-38596425-G-C not specified Uncertain significance (Feb 15, 2023)2463727
19-38596446-G-C not specified Uncertain significance (Mar 16, 2022)2278849
19-38597090-T-C not specified Uncertain significance (Dec 01, 2022)2410558
19-38597337-G-A not specified Uncertain significance (Dec 07, 2021)2397055
19-38597522-G-A not specified Uncertain significance (Jan 02, 2024)3123069
19-38600087-G-A not specified Uncertain significance (May 05, 2023)2512846
19-38600149-C-A not specified Uncertain significance (Apr 07, 2023)2534128
19-38601483-G-A not specified Uncertain significance (Jul 17, 2023)2601980
19-38605576-G-A not specified Uncertain significance (Sep 01, 2021)2412436
19-38605586-G-A not specified Uncertain significance (Apr 09, 2022)2282807
19-38605610-G-A not specified Uncertain significance (Apr 20, 2024)3293112
19-38605651-C-T not specified Uncertain significance (Feb 16, 2023)2455616
19-38605690-A-T not specified Uncertain significance (Nov 29, 2023)3123068
19-38605721-G-A not specified Uncertain significance (Dec 06, 2021)2264841
19-38607886-C-T not specified Uncertain significance (Dec 27, 2022)2339557
19-38607890-A-T Likely benign (Mar 01, 2024)3234627

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MAP4K1protein_codingprotein_codingENST00000591517 3231242
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9890.01081247830301248130.000120
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.132794700.5940.00002775316
Missense in Polyphen75180.910.414562037
Synonymous0.07751901910.9930.00001181688
Loss of Function5.62953.30.1690.00000279606

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009780.000961
Ashkenazi Jewish0.0001000.0000993
East Asian0.000.00
Finnish0.0001860.000186
European (Non-Finnish)0.00007070.0000618
Middle Eastern0.000.00
South Asian0.00003320.0000327
Other0.0001650.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Serine/threonine-protein kinase, which may play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. May play a role in hematopoietic lineage decisions and growth regulation. Able to autophosphorylate. {ECO:0000269|PubMed:24362026, ECO:0000269|PubMed:8824585}.;
Pathway
MAPK signaling pathway - Homo sapiens (human);EGF-Core;Androgen Receptor Network in Prostate Cancer;B Cell Receptor Signaling Pathway;Cardiac Hypertrophic Response;Signaling of Hepatocyte Growth Factor Receptor;TGF-beta Signaling Pathway;MAPK Signaling Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;EGF-EGFR Signaling Pathway;Insulin Signaling;T-Cell antigen Receptor (TCR) Signaling Pathway;mapkinase signaling pathway;TCR;TGF_beta_Receptor;BCR signaling pathway;Signaling events mediated by Stem cell factor receptor (c-Kit);JNK signaling in the CD4+ TCR pathway;TCR signaling in naïve CD4+ T cells (Consensus)

Intolerance Scores

loftool
0.542
rvis_EVS
-0.56
rvis_percentile_EVS
19.73

Haploinsufficiency Scores

pHI
0.745
hipred
Y
hipred_score
0.694
ghis
0.554

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.854

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Map4k1
Phenotype
hematopoietic system phenotype; immune system phenotype;

Gene ontology

Biological process
activation of MAPKKK activity;protein phosphorylation;activation of JUN kinase activity;cell population proliferation;peptidyl-serine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;protein autophosphorylation;cellular response to phorbol 13-acetate 12-myristate
Cellular component
cytoplasm;membrane
Molecular function
protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;MAP kinase kinase kinase kinase activity